Evidence map›Paper›PMID 37032756›Full record

ArticleTranslational andrology and urology2023

The

Xingxing Wang, Geng Chen, Peng Wu, Liangliang Ben, Qiang Liu, Jian Wang

Open access · diamondAbstract read
In one paragraph

Article in Translational andrology and urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xingxing WangDepartment of Urology, Affiliated Nantong Rehabilitation Hospital of Nantong University (The Second People's Hospital of Nantong), Nantong, China.
Geng ChenDepartment of Urology, Affiliated Nantong Rehabilitation Hospital of Nantong University (The Second People's Hospital of Nantong), Nantong, China.
Peng WuDepartment of Urology, Affiliated Nantong Rehabilitation Hospital of Nantong University (The Second People's Hospital of Nantong), Nantong, China.
Liangliang BenDepartment of Urology, Affiliated Nantong Rehabilitation Hospital of Nantong University (The Second People's Hospital of Nantong), Nantong, China.
Qiang LiuDepartment of Urology, Affiliated Nantong Rehabilitation Hospital of Nantong University (The Second People's Hospital of Nantong), Nantong, China.
Jian WangDepartment of Urology, Affiliated Nantong Rehabilitation Hospital of Nantong University (The Second People's Hospital of Nantong), Nantong, China.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Holmium laser enucleation of the prostate (HoLEP) is a new alternative method for the treatment of benign prostatic hyperplasia (BPH); however, most surgeons are hesitant to use this new technique due to its steep learning curve. Notably, most beginners start with the traditional multi-incisional method rather than the Methods: A clinical development project was established at Department of Urology, Affiliated Nantong Rehabilitation Hospital of Nantong University in December 2019 to promote HoLEP. The study included 1st 132 consecutive patients treated by a single surgeon between January and December 2020. The overall pre-, peri-, and post-operative metrics were documented and evaluated. The 132 patients were divided into Group A (1st 50 patients) and Group B (the following 82 patients), and these two groups were compared to each other. Results: No conversion of operative methods occurred. The major significant differences between Groups A and B related to the enucleation time and enucleation efficiency. We found that 20-30 procedures needed to be performed for the surgeon to become relatively comfortable with the Conclusions: The

Indexed as

Benign prostatic hyperplasia (BPH)en blocholmium laser enucleation of the prostate (HoLEP)learning curve

Identifiers

PMID37032756
PMCPMC10080358
OpenAlexW4360982012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.